Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades
MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.
Australian cannabis stocks have been red hot for the last few months.
- I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
- I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.
If you want to learn more about our member portfolio click here.
Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.
For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.
The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs"
Analysis originally distributed on August 16, 2017 By: Michael Vodicka of Cannabis Stock Trades
This week, I want to share AusCann Group Holdings Ltd. (NASDAQ:ACNNF)/ Cann Group (ASX:CAN) with the free newsletter crowd.
This is a stock I rolled out to members two weeks ago as one of our most recent trades. Members will always get the first look at the best ideas and information we have to offer at CST.
Since being added to the CST portfolio, Cann Group has been surging - Cannabis Stock Trades members are up around 75% on this trade.
2nd Australian Cannabis Permit Holder up 99% in 15 Days - More to Come?
Medical cannabis became legal in Australia in November of 2016.
Under the new program, companies interested in entering the industry must apply for and receive a permit from federal regulators to grow and sell cannabis. Continue reading "Cann Group Up 81% In 3 Weeks"
Analysis originally distributed on July 27, 2017 By: Michael Vodicka of Cannabis Stock Trades
In early 2017 Forbes ranked Warren Buffett as the world’s second richest man with a net worth of $72 billion.
Unlike most other billionaires on the list, Buffett didn’t get rich from owning just one company. Berkshire Hathaway Inc. (NYSE:BRK.B) functioned like a giant mutual fund, investing in many companies from different industries all across the economy. That way, if one industry or company struggled, it wouldn’t crush Berkshire’s performance.
At the core, this is a lesson in diversification. Putting all your eggs in one basket can be risky.
That is particularly true in the cannabis sector. It is a super young industry and cannabis stocks can be quite volatile.
I want to share a cannabis stock that Warren Buffett would love. Continue reading "Warren Buffet Would Love This Cannabis Stock"
Analysis originally distributed on July 19, 2017 By: Michael Vodicka of Cannabis Stock Trades
Cannabis is a proven treatment for cancer patients struggling with the side effects of chemotherapy such as nausea and loss of appetite.
But now, pre clinical research is showing that cannabis could actually be a cancer killer.
A group of scientists recently reported that THC and CBD slowed the growth and even killed certain cancer cells – including breast, brain and liver cancer – when grown in a lab.
Animal studies also suggest that cannabis could be a cancer killer.
A study conducted by Complutense University, one of the oldest and largest universities in Europe located in Madrid, showed that an injection of a synthetic THC eliminated malignant brain tumors in 1/3 of the rats studied while extending the life of another 1/3. Continue reading "Cannabis Cancer Stock Up 207% In 2017"
Analysis originally distributed on July 13, 2017 By: Michael Vodicka of Cannabis Stock Trades
There are millions of square feet of cannabis cultivation facilities being built all across North America.
Take Americann (OTC:ACAN) for example. Americann is a U.S. based cannabis company headquartered in Massachusetts. Americann is in the early stages of building a 1 million square foot cultivation facility in Mass that will potentially serve as the primary cultivation hub to supply a huge portion of the Eastern cannabis market.
Cronos Group (CDNX:MJN.V) is another good example. Cronos is a Canadian cannabis company headquartered in Toronto. In May, Cronos announced that one of the companies it owns, Peace, had broke ground on a 315,000 square foot cultivation facility.
This project will include a 286,000 square foot production facility, a 28,000 square foot greenhouse, and a 1,200 square foot extraction laboratory.
When finished, this facility is expected to be one of the largest indoor cannabis production facility in the world.
As you can see, cannabis companies are in the process of hugely ramping up their cultivation capacities to meet the tidal wave of demand for cannabis coming down the pike.
One way to profit is to simply invest in the companies building these cultivation facilities. That could turn out to be extremely profitable.
However, I have an even better way to potentially profit. Continue reading "More To Come For This Cannabis Lighting Company?"